SEC EDGAR · Amended filing
TDG: amended insider filing
An amended ownership report was filed. Read the original and amendment before comparing transactions.
Follow TDG- Became public
- Jul 21, 2026, 4:48 PM EDT
- Event / period date
- Jul 15, 2026
- Collected
- Nov 9, 2026, 4:57 PM EST
Why this is connected
This filing identifies TransDigm Group INC as the issuer of the security. The company's SEC identifier connects it to TDG.
Reported transactions
Reiss Joel (Co-Chief Operating Officer)
The filing marks a Rule 10b5-1 trading plan. Code P covers open-market and private purchases. Grants, option exercises, and tax withholding are excluded from purchase results. Read the source footnotes for ownership and pricing details.
Source evidence
Read the source excerpt or record
<?xml version="1.0"?>
<ownershipDocument>
<schemaVersion>X0609</schemaVersion>
<documentType>4/A</documentType>
<periodOfReport>2026-07-15</periodOfReport>
<dateOfOriginalSubmission>2026-07-16</dateOfOriginalSubmission>
<notSubjectToSection16>false</notSubjectToSection16>
<issuer>
<issuerCik>0001260221</issuerCik>
<issuerName>TransDigm Group INC</issuerName>
<issuerTradingSymbol>TDG</issuerTradingSymbol>
<issuerForeignTradingSymbol></issuerForeignTradingSymbol>
</issuer>
<reportingOwner>
<reportingOwnerId>
<rptOwnerCik>0001656109</rptOwnerCik>
<rptOwnerName>Reiss Joel</rptOwnerName>
</reportingOwnerId>
<reportingOwnerAddress>
<rptOwnerNonUSAddressFlag>false</rptOwnerNonUSAddressFlag>
<rptOwnerStreet1>1350 EUCLID AVE</rptOwnerStreet1>
<rptOwnerStreet2>SUITE 1600</rptOwnerStreet2>
<rptOwnerCity>CLEVELAND</rptOwnerCity>
<rptOwnerState>OH</rptOwnerState>
<rptOwnerZipCode>44115</rptOwnerZipCode>
<rptOwnerStateDescription></rptOwnerStateDescription>
</reportingOwnerAddress>
<reportingOwnerRelationship>
<isDirector>false</isDirector>
<isOfficer>true</isOfficer>
<isTenPercentOwner>false</isTenPercentOwner>
<isOther>false</isOther>
<officerTitle>Co-Chief Operating Officer</officerTitle>
<otherText></otherText>
</reportingOwnerRelationship>
</reportingOwner>
<aff10b5One>true</aff10b5One>
<nonDerivativeTable></nonDerivativeTable>
<derivativeTable>
<derivativeTransaction>
<securityTitle>
<value>Stock Option</value>
</securityTitle>
<conversionOrExercisePrice>
<value>284.97</value>
</conversionOrExercisePrice>
<transactionDate>
<value>2026-07-15</value>
</transactionDate>
<deemedExecutionDate></deemedExecutionDate>
<transactionCoding>
<transactionFormType>4</transactionFormType>
<transactionCode>M</transactionCode>
<equitySwapInvolved>false</equitySwapInvolved>
</transactionCoding>
<transactionTimeliness></transactionTimeliness>
<transactionAmounts>
<transactionShares>
<value>3900.00</value>
<footnoteId id="F1"/>
</transactionShares>
<transactionPricePerShare>
<value>0.00</value>
</transactionPricePerShare>
<transactionAcquiredDisposedCode>
<value>D</value>
</transactionAcquiredDisposedCode>
</transactionAmounts>
<exerciseDate>
<value>2021-09-30</value>
</exerciseDate>
<expirationDate>
<value>2027-11-08</value>
</expirationDate>
<underlyingSecurity>
<underlyingSecurityTitle>
<value>Common Stock</value>
</underlyingSecurityTitle>
<underlyingSecurityShares>
<value>3900.00</value>
</underlyingSecurityShares>
</underlyingSecurity>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value>11900.00</value>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value>D</value>
</directOrIndirectOwnership>
</ownershipNature>
</derivativeTransaction>
</derivativeTable>
<footnotes>
<footnote id="F1">This Form 4/A amends the Form 4 originally filed on 07.16.2026 to correct the reporting of the transaction in Table II, which was inadvertently reported as an acquisition ('A') rather than a disposition ('D'). No other changes have been made to the original filing.</footnote>
</footnotes>
<remarks></remarks>
<ownerSignature>
<signatureName>/s/ Rachel L. Quinlan as attorney in fact for Joel Reiss</signatureName>
<signatureDate>2026-07-21</signatureDate>
</ownerSignature>
</ownershipDocument>
Price change after we could observe it
+1.59% TDG
Adjusted closing prices from Nov 10, 2026 to Nov 11, 2026. SPY changed 1.32% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.
Congressional trading in TDG
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Sep 9, 2026$100K–$250K
Rep. April McClain Delaney (D-MD-6)
$100K–$250K · Traded Aug 25, 2026 · disclosed Sep 9, 2026 · Dependent
Committee overlap: Science - Aug 3, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded Jul 28, 2026 · disclosed Aug 3, 2026 · Dependent
Committee overlap: ScienceTraded 7 days before earnings - Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
- Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 22, 2026 · disclosed Jun 5, 2026 · Dependent
Committee overlap: Science - Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 21, 2026 · disclosed Jun 5, 2026 · Dependent
Committee overlap: Science - Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 13, 2026 · disclosed Jun 5, 2026 · Dependent
Committee overlap: Science - Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 8, 2026 · disclosed Jun 5, 2026 · Dependent
Committee overlap: Science - Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 7, 2026 · disclosed Jun 5, 2026 · Dependent
Committee overlap: Science
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.